Enanta Pharmaceuticals
ENTA
#7451
Rank
A$0.63 B
Marketcap
A$21.98
Share price
3.62%
Change (1 day)
76.99%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$0.33 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30A$0.35 B-6.18%
2023-09-30A$0.38 B354.35%
2022-09-30A$84.07 M54.45%
2021-09-30A$54.43 M27.68%
2020-09-30A$42.63 M5.31%
2019-09-30A$40.48 M42.31%
2018-09-30A$28.44 M-10.6%
2017-09-30A$31.81 M114.27%
2016-09-30A$14.84 M5.61%
2015-09-30A$14.05 M81.7%
2014-09-30A$7.73 M10.87%
2013-09-30A$6.97 M-12.22%
2012-09-30A$7.95 M86.99%
2011-09-30A$4.25 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AbbVie
ABBV
A$205.49 B 61,454.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 51,101.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$11.35 B 3,301.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$116.88 B 34,911.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$117.86 B 35,205.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.14 B 28,101.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland